PUBLISHER: TechNavio | PRODUCT CODE: 2144667
PUBLISHER: TechNavio | PRODUCT CODE: 2144667
Global Chemiluminescence Immunoassay Analyzers Market 2026-2030
The global chemiluminescence immunoassay analyzers market is forecasted to grow by USD 5251.6 mn during 2025-2030, accelerating at a CAGR of 11.2% during the forecast period. The report on the global chemiluminescence immunoassay analyzers market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of chronic and infectious diseases requiring immunodiagnostic testing, growing demand for high-throughput laboratory automation solutions, advancing healthcare infrastructure investment across emerging economies.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
| Market Scope | |
|---|---|
| Base Year | 2025 |
| End Year | 2030 |
| Series Year | 2026-2030 |
| Growth Momentum | Accelerate |
| YOY 2026 | 11% |
| CAGR | 11.2% |
| Incremental Value | $5251.6 mn |
Technavio's global chemiluminescence immunoassay analyzers market is segmented as below:
By End-User
- Hospitals
- Clinical laboratories
- Pharma and biotech companies
- Others
By Product
- Instruments
- Consumables
- Software and services
By Type
- Medium-throughput
- High-throughput
- Low-throughput
Geography
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Asia
- Rest of World (ROW)
- Rest of World (ROW)
This study identifies the evolving integration of ai-enabled analytical interpretation within diagnostic workflows as one of the prime reasons driving the global chemiluminescence immunoassay analyzers market growth during the next few years. Also, expanding adoption of multiplex testing capabilities across laboratory networks and increasing shift toward connected laboratory ecosystems and remote instrument monitoring will lead to sizable demand in the market.
The report on the global chemiluminescence immunoassay analyzers market covers the following areas:
- Global chemiluminescence immunoassay analyzers market sizing
- Global chemiluminescence immunoassay analyzers market forecast
- Global chemiluminescence immunoassay analyzers market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global chemiluminescence immunoassay analyzers market vendors that include Abbott Laboratories, Autobio Diagnostics Co. Ltd., Beckman Coulter Inc., Beijing Hotgen Biotech Co. Ltd., DAAN Gene Co. Ltd., DiaSorin SpA, Erba Mannheim, F. Hoffmann La Roche Ltd., Fosun Diagnostics, Fujirebio Holdings Inc., Getein Biotech Inc., Guangzhou Wondfo Biotech Co., Maccura Biotechnology Co. Ltd., QuidelOrtho Corp., Shenzhen Mindray Co. Ltd., Shenzhen YHLO Biotech Co. Ltd, Siemens Healthineers AG, Snibe Co.Ltd., Sysmex Corp., Tosoh Corp.. Also, the global chemiluminescence immunoassay analyzers market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
- 1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by End-user
- Executive Summary - Chart on Market Segmentation by Product
- Executive Summary - Chart on Market Segmentation by Type
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis
- 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- 2.2 Criticality of inputs and Factors of differentiation
- 2.3 Factors of disruption
- 2.4 Impact of drivers and challenges
3 Market Landscape
- 3.1 Market ecosystem
- 3.2 Market characteristics
- 3.3 Value chain analysis
4 Market Sizing
- 4.1 Market definition
- 4.2 Market segment analysis
- Market segments
- 4.3 Market size 2025
- 4.4 Market outlook: Forecast for 2025-2030
5 Historic Market Size
- 5.1 Global Chemiluminescence Immunoassay Analyzers Market 2020 - 2024
- Historic Market Size - Data Table on Global Chemiluminescence Immunoassay Analyzers Market 2020 - 2024 ($ million)
- 5.2 End-user segment analysis 2020 - 2024
- Historic Market Size - End-user Segment 2020 - 2024 ($ million)
- 5.3 Product segment analysis 2020 - 2024
- Historic Market Size - Product Segment 2020 - 2024 ($ million)
- 5.4 Type segment analysis 2020 - 2024
- Historic Market Size - Type Segment 2020 - 2024 ($ million)
- 5.5 Geography segment analysis 2020 - 2024
- Historic Market Size - Geography Segment 2020 - 2024 ($ million)
- 5.6 Country segment analysis 2020 - 2024
- Historic Market Size - Country Segment 2020 - 2024 ($ million)
6 Qualitative Analysis
- 6.1 Impact of AI on global chemiluminescence immunoassay analyzers market
- 6.2 Impact of geopolitical conflicts on global chemiluminescence immunoassay analyzers market
7 Five Forces Analysis
- 7.1 Five forces summary
- Five forces analysis - Comparison between 2025 and 2030
- 7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2025 and 2030
- 7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2025 and 2030
- 7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2025 and 2030
- 7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2025 and 2030
- 7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2025 and 2030
- 7.7 Market condition
8 Market Segmentation by End-user
- 8.1 Market segments
- 8.2 Comparison by End-user
- 8.3 Hospitals - Market size and forecast 2025-2030
- 8.4 Clinical laboratories - Market size and forecast 2025-2030
- 8.5 Pharma and biotech companies - Market size and forecast 2025-2030
- 8.6 Others - Market size and forecast 2025-2030
- 8.7 Market opportunity by End-user
- Market opportunity by End-user ($ million)
9 Market Segmentation by Product
- 9.1 Market segments
- 9.2 Comparison by Product
- 9.3 Instruments - Market size and forecast 2025-2030
- 9.4 Consumables - Market size and forecast 2025-2030
- 9.5 Software and services - Market size and forecast 2025-2030
- 9.6 Market opportunity by Product
- Market opportunity by Product ($ million)
10 Market Segmentation by Type
- 10.1 Market segments
- 10.2 Comparison by Type
- 10.3 Medium-throughput - Market size and forecast 2025-2030
- 10.4 High-throughput - Market size and forecast 2025-2030
- 10.5 Low-throughput - Market size and forecast 2025-2030
- 10.6 Market opportunity by Type
- Market opportunity by Type ($ million)
11 Customer Landscape
- 11.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
12 Geographic Landscape
- 12.1 Geographic segmentation
- 12.2 Geographic comparison
- 12.3 North America - Market size and forecast 2025-2030
- 12.3.1 US - Market size and forecast 2025-2030
- 12.3.2 Canada - Market size and forecast 2025-2030
- 12.3.3 Mexico - Market size and forecast 2025-2030
- 12.4 Europe - Market size and forecast 2025-2030
- 12.4.1 Germany - Market size and forecast 2025-2030
- 12.4.2 UK - Market size and forecast 2025-2030
- 12.4.3 France - Market size and forecast 2025-2030
- 12.4.4 Italy - Market size and forecast 2025-2030
- 12.4.5 Spain - Market size and forecast 2025-2030
- 12.4.6 The Netherlands - Market size and forecast 2025-2030
- 12.5 Asia - Market size and forecast 2025-2030
- 12.5.1 China - Market size and forecast 2025-2030
- 12.5.2 Japan - Market size and forecast 2025-2030
- 12.5.3 India - Market size and forecast 2025-2030
- 12.5.4 South Korea - Market size and forecast 2025-2030
- 12.5.5 Indonesia - Market size and forecast 2025-2030
- 12.5.6 Thailand - Market size and forecast 2025-2030
- 12.6 Rest of World (ROW) - Market size and forecast 2025-2030
- 12.6.1 Brazil - Market size and forecast 2025-2030
- 12.6.2 Saudi Arabia - Market size and forecast 2025-2030
- 12.6.3 UAE - Market size and forecast 2025-2030
- 12.6.4 South Africa - Market size and forecast 2025-2030
- 12.6.5 Argentina - Market size and forecast 2025-2030
- 12.6.6 Turkey - Market size and forecast 2025-2030
- 12.6.7 Colombia - Market size and forecast 2025-2030
- 12.6.8 Israel - Market size and forecast 2025-2030
- 12.7 Market opportunity by geography
- Market opportunity by geography ($ million)
- Data Tables on Market opportunity by geography ($ million)
13 Drivers, Challenges, and Opportunity
- 13.1 Market drivers
- Increasing prevalence of chronic and infectious diseases requiring immunodiagnostic testing
- Growing demand for high-throughput laboratory automation solutions
- Advancing healthcare infrastructure investment across emerging economies
- 13.2 Market challenges
- Regulatory approval complexity across multiple healthcare jurisdictions
- High ownership and maintenance costs for advanced diagnostic systems
- Workforce shortages in laboratory operations and clinical diagnostics
- 13.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2025 and 2030
- 13.4 Market opportunities
- Evolving integration of AI-enabled analytical interpretation within diagnostic workflows
- Expanding adoption of multiplex testing capabilities across laboratory networks
- Increasing shift toward connected laboratory ecosystems and remote instrument monitoring
14 Competitive Landscape
- 14.1 Overview
- 14.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- 14.3 Landscape disruption
- Overview on factors of disruption
- 14.4 Industry risks
- Impact of key risks on business
15 Competitive Analysis
- 15.1 Companies profiled
- Companies covered
- 15.2 Company ranking index
- Company ranking index
- 15.3 Market positioning of companies
- Matrix on companies position and classification
- 15.4 Abbott Laboratories
- Abbott Laboratories - Overview
- Abbott Laboratories - Business segments
- Abbott Laboratories - Key news
- Abbott Laboratories - Key offerings
- Abbott Laboratories - Segment focus
- SWOT
- 15.5 Autobio Diagnostics Co. Ltd.
- Autobio Diagnostics Co. Ltd. - Overview
- Autobio Diagnostics Co. Ltd. - Product / Service
- Autobio Diagnostics Co. Ltd. - Key offerings
- SWOT
- 15.6 DAAN Gene Co. Ltd.
- DAAN Gene Co. Ltd. - Overview
- DAAN Gene Co. Ltd. - Product / Service
- DAAN Gene Co. Ltd. - Key offerings
- SWOT
- 15.7 DiaSorin SpA
- DiaSorin SpA - Overview
- DiaSorin SpA - Business segments
- DiaSorin SpA - Key news
- DiaSorin SpA - Key offerings
- DiaSorin SpA - Segment focus
- SWOT
- 15.8 F. Hoffmann La Roche Ltd.
- F. Hoffmann La Roche Ltd. - Overview
- F. Hoffmann La Roche Ltd. - Business segments
- F. Hoffmann La Roche Ltd. - Key news
- F. Hoffmann La Roche Ltd. - Key offerings
- F. Hoffmann La Roche Ltd. - Segment focus
- SWOT
- 15.9 Getein Biotech Inc.
- Getein Biotech Inc. - Overview
- Getein Biotech Inc. - Product / Service
- Getein Biotech Inc. - Key offerings
- SWOT
- 15.10 Guangzhou Wondfo Biotech Co.
- Guangzhou Wondfo Biotech Co. - Overview
- Guangzhou Wondfo Biotech Co. - Product / Service
- Guangzhou Wondfo Biotech Co. - Key offerings
- SWOT
- 15.11 Maccura Biotechnology Co. Ltd.
- Maccura Biotechnology Co. Ltd. - Overview
- Maccura Biotechnology Co. Ltd. - Product / Service
- Maccura Biotechnology Co. Ltd. - Key offerings
- SWOT
- 15.12 QuidelOrtho Corp.
- QuidelOrtho Corp. - Overview
- QuidelOrtho Corp. - Business segments
- QuidelOrtho Corp. - Key offerings
- QuidelOrtho Corp. - Segment focus
- SWOT
- 15.13 Shenzhen Mindray Co. Ltd.
- Shenzhen Mindray Co. Ltd. - Overview
- Shenzhen Mindray Co. Ltd. - Business segments
- Shenzhen Mindray Co. Ltd. - Key offerings
- Shenzhen Mindray Co. Ltd. - Segment focus
- SWOT
- 15.14 Shenzhen YHLO Biotech Co. Ltd
- Shenzhen YHLO Biotech Co. Ltd - Overview
- Shenzhen YHLO Biotech Co. Ltd - Business segments
- Shenzhen YHLO Biotech Co. Ltd - Key offerings
- Shenzhen YHLO Biotech Co. Ltd - Segment focus
- SWOT
- 15.15 Siemens Healthineers AG
- Siemens Healthineers AG - Overview
- Siemens Healthineers AG - Business segments
- Siemens Healthineers AG - Key offerings
- Siemens Healthineers AG - Segment focus
- SWOT
- 15.16 Snibe Co.Ltd.
- Snibe Co.Ltd. - Overview
- Snibe Co.Ltd. - Product / Service
- Snibe Co.Ltd. - Key offerings
- SWOT
- 15.17 Sysmex Corp.
- Sysmex Corp. - Overview
- Sysmex Corp. - Business segments
- Sysmex Corp. - Key news
- Sysmex Corp. - Key offerings
- Sysmex Corp. - Segment focus
- SWOT
- 15.18 Tosoh Corp.
- Tosoh Corp. - Overview
- Tosoh Corp. - Business segments
- Tosoh Corp. - Key offerings
- Tosoh Corp. - Segment focus
- SWOT
16 Appendix
- 16.1 Scope of the report
- Market definition
- Objectives
- Notes and caveats
- 16.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
- 16.3 Currency conversion rates for US$
- Currency conversion rates for US$
- 16.4 Research methodology
- Research methodology
- 16.5 Data procurement
- Information sources
- 16.6 Data validation
- Data validation
- 16.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
- 16.8 Data synthesis
- Data synthesis
- 16.9 360 degree market analysis
- 360 degree market analysis
- 16.10 List of abbreviations
- List of abbreviations
